Light Mode
$0.0000 ↓ -0.0001 (-99.00%) Trading Down from the previous close of $0.0001, and at the day’s high of $0.0000
-0.01 (+0.00%) / 6M
Momentum, market sentiment, and recent alerts
IOBTQ reads n/a: the 12-month move is -100.0%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
IO Biotech, Inc. engages in the development of immune modulating cancer therapies based on its T-win technology platform. Its platform is a novel approach to cancer immunotherapy designed to activate naturally occurring T cells to target immunosuppressive mechanisms. The company was founded by Mai-Britt Zocca, Inge Marie Svane, and Mads Hald Andersen in December 2014 and is headquartered in Copenhagen, Denmark.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.